Personalized Medicine in Epilepsy: Why One Treatment Doesn’t Fit Everyone

•

When someone is diagnosed with epilepsy, one of the first questions they may ask is which treatment will work best. With so many antiseizure medications and other treatment options available, it might seem like finding the right treatment should be straightforward. In reality, epilepsy is not a single condition with one cause or one predictable treatment response. Different people can experience different seizure types, have different underlying causes, and respond differently to the same medication. This is why personalized medicine is becoming an increasingly important area of epilepsy research and clinical care. Rather than assuming that everyone should receive the same treatment, personalized medicine aims to use information about an individual’s condition, biology, medical history, and treatment response to guide decisions. Although this approach is still developing, it is already influencing how some forms of epilepsy are diagnosed and treated.

What Is Personalized Medicine?

Moving Beyond a One-Size-Fits-All Approach

Personalized medicine, sometimes called precision medicine, involves tailoring healthcare decisions to the characteristics of an individual.

In epilepsy, this can mean selecting treatment based on the person’s seizure type, epilepsy syndrome, suspected cause, genetic findings, other medical conditions, and response to previous medications.

For example, two people may both have seizures but have different underlying forms of epilepsy. A medication that works well for one person may be less effective or inappropriate for the other.

Treatment decisions may also depend on age, other medications, possible side effects, and individual circumstances.

A systematic review by Agarwal et al. (2024) examined how genetic markers and individualized treatment strategies are being used in epilepsy care. The review highlights the potential for precision medicine to improve treatment selection and reduce unnecessary adverse effects.

The goal is not to create a completely different treatment for every person. It is to use relevant information to make better-informed decisions about which available options are most appropriate.

Why Epilepsy Is So Complex

Epilepsy includes many different disorders, and seizures can arise for a variety of reasons.

Potential causes include genetic conditions, structural changes in the brain, previous brain injuries, infections, and other neurological factors. In some cases, the underlying cause remains unknown despite investigation.

Even when two people experience similar-looking seizures, the neurological mechanisms contributing to those seizures may differ.

This complexity helps explain why a single treatment approach does not work equally well for everyone.

Understanding the type of epilepsy and, when possible, its underlying cause can help healthcare professionals choose treatments more appropriately.

The Role of Genetics in Epilepsy Treatment

1. Genetic Testing Can Help Identify the Cause

Some forms of epilepsy are associated with changes in specific genes.

These genetic findings can sometimes explain why seizures developed and may provide information about the likely course of the condition.

Genetic testing is not necessary or informative for every person with epilepsy. However, it can be particularly useful when the clinical presentation suggests a genetic cause, such as certain early-onset epilepsies, unexplained developmental difficulties, or specific epilepsy syndromes.

Depending on the circumstances, testing may involve epilepsy gene panels, exome sequencing, genome sequencing, or other approaches recommended by a specialist.

A genetic result must be interpreted carefully. Not every genetic variant is disease-causing, and some results may remain uncertain.

Genetic counseling can help individuals and families understand what a result means, what it does not mean, and whether additional testing or follow-up may be appropriate.

2. Genetic Findings Can Influence Treatment

One of the most important potential benefits of genetic diagnosis is that it may affect treatment decisions.

Certain genetic epilepsies involve biological pathways that respond differently to particular medications or treatments.

For example, some epilepsy syndromes associated with SCN1A gene variants require particular care when selecting sodium-channel-blocking medications, because certain drugs may worsen seizures in some affected individuals.

However, the effect depends on the specific condition and clinical context. Genetic findings should always be interpreted by a qualified specialist rather than used independently to start or stop medication.

In other genetic epilepsies, identifying a particular cause may help clinicians consider targeted therapies or determine whether a treatment is unlikely to be useful.

This illustrates why understanding the cause of epilepsy can sometimes be just as important as identifying the seizure type.

3. Genetic Testing Does Not Guarantee a Cure

Although genetic testing can provide valuable information, it does not automatically identify an effective treatment.

Some genetic findings have clear clinical implications, while others provide information about the likely diagnosis without immediately changing treatment.

In addition, many people with epilepsy do not have a single identifiable genetic cause.

Personalized medicine therefore involves more than DNA testing. It may also incorporate clinical observations, imaging, electroencephalography (EEG), treatment history, and other relevant information.

The purpose is to build a more complete picture of the person’s epilepsy rather than relying on one test alone.

Why Medication Responses Differ Between People

1. Different Seizure Types Require Different Considerations

Antiseizure medications are not interchangeable in every situation.

Some medications are effective for particular seizure types but may be less appropriate for others. Certain medications can even worsen some seizure types or epilepsy syndromes.

For this reason, clinicians need to establish the most accurate diagnosis possible before selecting treatment.

EEG findings, seizure descriptions, medical history, and other investigations may all contribute to that decision.

Choosing a medication based only on the fact that someone has seizures would overlook important differences between epilepsy conditions.

2. Side Effects Are Individual

Even when a medication is appropriate for a particular seizure type, people may respond differently to it.

One person may tolerate a medication well, while another experiences fatigue, dizziness, mood changes, or other side effects.

These differences can depend on several factors, including the medication’s properties, dose, other medications, individual physiology, and underlying health conditions.

Treatment decisions therefore involve balancing seizure control against potential side effects and their impact on daily life.

For example, a medication that reduces seizures but causes substantial daytime sleepiness may create difficulties for someone who needs to drive when medically permitted, attend classes, or perform work requiring sustained attention.

Healthcare providers can evaluate whether a different dose, alternative medication, or other adjustment may be appropriate.

People should never change or discontinue antiseizure medication without medical guidance, because doing so can increase seizure risk.

3. Genetics Can Influence How the Body Processes Medication

The body uses enzymes and other biological systems to absorb, distribute, break down, and eliminate medications.

Genetic differences can affect some of these processes.

This area of research is known as pharmacogenomics, which studies how genetic variation influences medication response.

In epilepsy care, pharmacogenomic information may be useful in selected circumstances, particularly when a genetic variant has an established relationship with medication safety or metabolism.

However, genetic testing cannot currently predict every person’s response to every antiseizure medication.

For many medications, clinical factors such as seizure type, other health conditions, interacting drugs, and observed treatment response remain essential to decision-making.

Personalized prescribing combines the available evidence rather than relying on genetics alone.

The Role of EEG and Brain Imaging

1. EEG Helps Characterize Seizure Activity

An electroencephalogram, or EEG, records electrical activity in the brain using electrodes placed on the scalp.

EEG findings can help clinicians identify patterns associated with particular epilepsy syndromes and distinguish between different types of seizure disorders.

For example, certain electrical patterns may support a diagnosis of a generalized epilepsy syndrome, while others may suggest focal seizure activity.

EEG findings must be interpreted alongside a person’s symptoms and medical history. A normal routine EEG does not automatically rule out epilepsy.

In some cases, longer recordings or video-EEG monitoring may provide additional information.

These findings can help clinicians refine the diagnosis and select more appropriate treatment options.

2. Brain Imaging Can Reveal Structural Causes

Magnetic resonance imaging (MRI) can identify certain structural abnormalities associated with epilepsy.

Examples include areas of abnormal brain development, previous injuries, tumors, or other changes that may contribute to seizures.

Identifying a structural cause can sometimes affect treatment planning.

For selected people whose seizures do not respond adequately to medication, additional investigations may help determine whether epilepsy surgery or another specialized treatment should be considered.

Imaging is only one part of the assessment, however. Not everyone with epilepsy has an identifiable abnormality on MRI, and a normal scan does not mean the seizures are not real.

Combining imaging with clinical information and EEG results can provide a more complete understanding of the condition.

Personalized Treatment Beyond Medication

1. Epilepsy Surgery

For some people whose seizures continue despite appropriate medication trials, epilepsy surgery may be an option.

Surgery is not suitable for everyone. Candidates generally undergo detailed evaluation to determine where seizures originate, whether the responsible area can be treated safely, and what benefits and risks surgery may involve.

For appropriately selected individuals, surgery can substantially reduce seizures and may sometimes result in long-term seizure freedom.

This is an example of personalized treatment because decisions depend on the person’s seizure origin, brain anatomy, medical history, and individual circumstances.

2. Neurostimulation

Some people may be candidates for devices that deliver electrical stimulation to specific nerves or brain networks to help reduce seizures.

Options include vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation in selected circumstances.

These treatments differ in how they work, who may be eligible, and how they are used.

They generally aim to reduce seizure frequency rather than guarantee complete seizure freedom.

A specialist can determine whether a particular approach is appropriate based on the individual’s epilepsy and previous treatment response.

3. Dietary Therapies

Certain dietary therapies, including the ketogenic diet and related approaches, can help some people with epilepsy, particularly in specific clinical circumstances.

These diets change the body’s use of energy sources and may influence processes involved in seizure activity.

However, they require careful planning and medical supervision, especially for children and individuals with other health conditions.

They are not suitable for everyone and should not be attempted as a substitute for prescribed treatment without professional guidance.

Personalized epilepsy care considers whether the potential benefits of a dietary therapy outweigh its practical demands and medical risks for the individual.

The Challenges of Personalized Medicine

1. Not Everyone Has Access to Advanced Testing

Genetic testing, specialized imaging, comprehensive epilepsy evaluations, and precision treatments may not be equally available to everyone.

Cost, insurance coverage, geographic location, and access to specialists can affect whether someone receives these services.

Even when testing is available, interpreting the results may require expertise that is not accessible in every healthcare setting.

Improving access to appropriate diagnostic testing and specialized care remains an important challenge.

2. Not Every Test Produces a Clear Answer

Medical testing does not always reveal a definitive cause.

A genetic test may identify a variant whose significance is uncertain, or imaging may fail to identify a structural explanation.

These results can be frustrating for patients and families who are hoping for a clear diagnosis.

However, an inconclusive result does not mean that a person’s symptoms are unimportant or that treatment cannot help.

Clinicians can still use seizure characteristics, EEG findings, medical history, and observed medication responses to guide care.

3. Precision Medicine Is Still Developing

Although personalized medicine has already influenced some aspects of epilepsy treatment, many approaches remain under investigation.

Researchers are studying additional genetic markers, biological pathways, biomarkers, and methods for predicting treatment response.

The long-term goal is to identify which treatments are most likely to help particular individuals while reducing unnecessary medication trials and side effects.

However, a promising research finding is not automatically a clinically validated treatment.

Further studies are needed to establish which approaches reliably improve outcomes and which patients are most likely to benefit.

What This Means for People Living With Epilepsy

Personalized medicine reinforces an important principle: epilepsy treatment should be based on the individual, not simply the diagnosis.

If seizures continue despite treatment, it may be appropriate to discuss whether the epilepsy type has been fully characterized, whether additional investigations are warranted, and whether other treatment options should be considered.

Patients can also help their healthcare providers by describing seizure patterns, medication side effects, sleep changes, and other relevant experiences.

Keeping a seizure diary may provide useful information, although the diary should not replace medical evaluation.

People should feel comfortable discussing concerns about treatment effectiveness and quality of life. These factors are important parts of individualized care.

Conclusion

Personalized medicine is changing how researchers and clinicians think about epilepsy treatment.

Rather than assuming that one medication or treatment will work for everyone, this approach recognizes that epilepsy has many causes, seizure types, and biological mechanisms.

Genetic testing, EEG, brain imaging, treatment history, and other clinical information can help healthcare providers understand an individual’s condition more precisely.

For some people, this information may influence medication selection, identify targeted treatment opportunities, or support consideration of specialized therapies such as surgery or neurostimulation.

However, personalized medicine is not a guarantee of seizure freedom, and many approaches remain under investigation. Access to advanced testing and specialist care also varies.

Even so, the central idea is valuable: treatment decisions should reflect the person’s actual needs, medical circumstances, and response to care.

As research advances, personalized approaches may help more people find treatments that control seizures while supporting their overall quality of life.

References

Agarwal, M., et al. (2024). Precision Medicine Approaches in Epilepsy: A Systematic Review of Genetic Markers and Personalized Treatment Strategies. Precision Medical Sciences, 13(2), 72–83.

International League Against Epilepsy (ILAE). (n.d.). Genetics and Epilepsy.

National Institute of Neurological Disorders and Stroke (NINDS). (n.d.). Epilepsy and Seizures.

National Center for Biotechnology Information (NCBI). (n.d.). Pharmacogenomics and Antiseizure Medications.

Epilepsy Foundation. (n.d.). Genetic Testing and Epilepsy.

World Health Organization (WHO). (2024). Epilepsy.